Ligands and Coordination Chemistry
Miles Mathis' Charge Field :: Miles Mathis Charge Field :: The Charge Field Effects on Humans/Animals
Page 1 of 1
Ligands and Coordination Chemistry
Since Mathis redefines "Van Der Waals forces" in his work, this may be another phenomenon requiring a Charge Field interpretation.
-----------------------------------------------
Ligand (biochemistry)
From Wikipedia, the free encyclopedia
This article is about ligands in biochemistry. For ligands in inorganic chemistry, see Ligand. For other uses, see Ligand (disambiguation).
Myoglobin (blue) with its ligand heme (orange) bound. Based on PDB [2]
In biochemistry and pharmacology, a ligand is a substance (usually a small molecule) that forms a complex with a biomolecule to serve a biological purpose. In protein-ligand binding, the ligand is usually a signal-triggering molecule, binding to a site on a target protein. In DNA-ligand binding studies, the ligand is usually any small molecule or ion,[1] or even a protein [2] that binds to the DNA double helix.
The binding occurs by intermolecular forces, such as ionic bonds, hydrogen bonds and van der Waals forces. The docking (association) is usually reversible (dissociation). Actual irreversible covalent bonding between a ligand and its target molecule is rare in biological systems. In contrast to the meaning in metalorganic and inorganic chemistry, it is irrelevant whether the ligand actually binds at a metal site, as is the case in hemoglobin.
Ligand binding to a receptor (receptor protein) alters its chemical conformation (three-dimensional shape). The conformational state of a receptor protein determines its functional state. Ligands include substrates, inhibitors, activators, and neurotransmitters. The tendency or strength of binding is called affinity. Binding affinity is determined not only by direct interactions, but also by solvent effects that can play a dominant indirect role in driving non-covalent binding in solution.[3]
Radioligands are radioisotope labeled compounds are used in vivo as tracers in PET studies and for in vitro binding studies.
-----
Reactivity in Chemistry
I− < Br− < S2− < SCN− < Cl− < NO3− < N3− < F− < OH− < C2O42− < H2O < NCS− < CH3CN < py < NH3 < en < bipy < phen < NO2− < PPh3 < CN− < CO
in which py = pyridine; en = ethylenediamine; bipy = 2,2'-bipyridine; phen = 1,10-phenanthroline; SCN means the ligand is bound via sulfur and NCS via nitrogen.
This site is written and maintained by Chris P. Schaller, Ph.D., College of Saint Benedict / Saint John's University (with contributions from other authors as noted). It is freely available for educational use.
[url=http://employees.csbsju.edu/cschaller/Reactivity/coordchem/coordchem spectrochem.htm]http://employees.csbsju.edu/cschaller/Reactivity/coordchem/coordchem%20spectrochem.htm[/url]
-----------------------------------------------
Ligand (biochemistry)
From Wikipedia, the free encyclopedia
This article is about ligands in biochemistry. For ligands in inorganic chemistry, see Ligand. For other uses, see Ligand (disambiguation).
Myoglobin (blue) with its ligand heme (orange) bound. Based on PDB [2]
In biochemistry and pharmacology, a ligand is a substance (usually a small molecule) that forms a complex with a biomolecule to serve a biological purpose. In protein-ligand binding, the ligand is usually a signal-triggering molecule, binding to a site on a target protein. In DNA-ligand binding studies, the ligand is usually any small molecule or ion,[1] or even a protein [2] that binds to the DNA double helix.
The binding occurs by intermolecular forces, such as ionic bonds, hydrogen bonds and van der Waals forces. The docking (association) is usually reversible (dissociation). Actual irreversible covalent bonding between a ligand and its target molecule is rare in biological systems. In contrast to the meaning in metalorganic and inorganic chemistry, it is irrelevant whether the ligand actually binds at a metal site, as is the case in hemoglobin.
Ligand binding to a receptor (receptor protein) alters its chemical conformation (three-dimensional shape). The conformational state of a receptor protein determines its functional state. Ligands include substrates, inhibitors, activators, and neurotransmitters. The tendency or strength of binding is called affinity. Binding affinity is determined not only by direct interactions, but also by solvent effects that can play a dominant indirect role in driving non-covalent binding in solution.[3]
Radioligands are radioisotope labeled compounds are used in vivo as tracers in PET studies and for in vitro binding studies.
-----
Reactivity in Chemistry
Coordination Chemistry
CC9. Spectrochemical Series
Another factor that plays a key role in whether a transition metal complex is high- or low-spin is the nature of the ligands. The d orbital energy splitting is influenced by how strongly the ligand interacts with the metal. Ligands that interact only weakly produce little change in the d orbital energy levels, whereas ligands that interact strongly produce a larger change in d orbital energy levels.
The spectrochemical series is a list of ligands based on the strength of their interaction with metal ions. It is often listed, from weaker to stronger ligands, something like this:
I− < Br− < S2− < SCN− < Cl− < NO3− < N3− < F− < OH− < C2O42− < H2O < NCS− < CH3CN < py < NH3 < en < bipy < phen < NO2− < PPh3 < CN− < CO
in which py = pyridine; en = ethylenediamine; bipy = 2,2'-bipyridine; phen = 1,10-phenanthroline; SCN means the ligand is bound via sulfur and NCS via nitrogen.
The list can vary from one metal ion to another, since some ligands bind preferentially to certain metals (as seen in hard and soft acid and base chemistry).
Problem CC9.1.
What empirical trends can you see within the spectrochemical series? Are there any factors that make something a stronger field ligand?
The d orbitals that rise in energy in the presence of a ligand can be thought of as forming an antibonding molecular orbital combination with an orbital on the ligand. In addition, there would also be a bonding combination for this interaction. That bonding orbital would be more like the initial ligand orbital. This premise is based on the idea that a ligand orbital is initially lower in energy than the metal orbital, so a bonding combination between these two orbitals is more like the initial ligand orbital, both in energy and location. The d orbital is initially higher in energy than the ligand orbital, so an antibonding combination between these two orbitals is more like the initial d orbital, both in energy and location.
- When orbitals on two different kinds of atoms combine, the antibonding orbital is considered to be more like the orbital that was initially at higher energy.
- In this case, it is still close to a d orbital in energy, location, and shape.
- When orbitals on two different kinds of atoms combine, the bonding orbital is considered to be more like the orbital that was initially at lower energy.
Problem CC9.2.
Suppose a ligand has more than one lone pair on the donor atom. The donor atom could share an extra pair of electrons with the metal, to form a double bond. This type of interaction is called pi-donation, because a pi bond is formed (not to be confused with sigma donation from a pi bond, as in alkene binding). Show an example using Ti(OiPr)4.
Problem CC9.3.
In an octahedral environment, three of the d orbitals were not affected by sigma donation from the ligands. Show what happens to the energy level of these d orbitals in the presence of a pi donor.
Problem CC9.4.
Some ligands can accept a pair of electrons from the metal. An example is a carbonyl complex, which has a C=O pi antibonding orbital that can interact with a d orbital.a) Show the antibonding orbital on the carbonyl (CO) ligand.b) Show how a metal d orbital can interact with this orbital.
Problem CC9.5.
In the previous problem, a lower-energy atomic orbital on the metal interacts with a higher-energy antibonding orbital on the ligand. Show what happens to the energies of these two orbitals when they interact with each other.
Some of the trends we see in the spectrochemical series arise from pi-donating and pi-accepting effects in the ligand. Ligands that have additional lone pairs (other than the one hat sigma donates) are pi donors. Pi donors raise the otherwise non-bonding t2g orbitals, because the lone pair on the ligand forms a pi bond with the metal. The t2g orbitals and the ligand lone pair orbitals form two new orbitals. The antibonding orbital is closer in energy to the high-energy d orbitals. The bonding orbital is closer in energy to the low-energy ligand orbital.
- Pi donation raises the t2g set of d orbitals in energy.
- As a result, the d orbital splitting gets smaller.
- Also as a result, a complex with pi donation is a little less stable than a complex without pi donation.
This type of interaction can be seen in the following pictures (a tetrahedral case).
On the other hand, ligands in which the donor atom is already pi bonding to another atom can accept pi donation from the metal. This happens by donating an electron pair from a metal t2g orbital into a pi* orbital on the ligand. In this case, because the pi* is an antibonding orbital, it is higher in energy than the metal d orbital (or the t2g orbital). The resulting bonding orbital is more like the lower energy metal orbital, whereas the resulting antibonding orbital is more like the higher energy pi* orbital on the ligand.
- Pi accepting ligands lower the t2g set of d orbitals in energy.
- As a result, the d orbital splitting gets larger.
- Also as a result, a complex with a pi accepting ligand is a little more stable than a complex without a pi accepting ligand.
This type of interaction can be seen in the following case (a tetrahedral complex).
The spectrochemical series gets its name because of a shift in a band of the UV-Vis spectrum when two similar complexes are compared that have two different ligands. The effect of the ligand on the d orbital splitting has an effect on the wavelength of light associated with a d orbital (filled) to d orbital (empty) electronic transition. This transition is actually not associated with a major absorption. However, because it often occurs in the region of visible light, it is often be associated with coloured transition metal complexes.
Problem CC9.6.
Explain what happens to the wavelength of light absorbed for the d-d transition when a chloride ligand on a metal complex is replaced with a hydroxide ligand.
ProblemCC9.7.
Predict whether each of these coordination complexes is low spin or high spin.
a) [Co(NH3)6]+3 b) [Fe(CN)6]-4 c) [CoF6]-4
d) [Rh(CN)6]-3 e) [V(OH2)6]+3 f) [Fe(py)6]+2
g) [MnCl6]-4 h) [Ru(NH3)6]+2
This site is written and maintained by Chris P. Schaller, Ph.D., College of Saint Benedict / Saint John's University (with contributions from other authors as noted). It is freely available for educational use.
[url=http://employees.csbsju.edu/cschaller/Reactivity/coordchem/coordchem spectrochem.htm]http://employees.csbsju.edu/cschaller/Reactivity/coordchem/coordchem%20spectrochem.htm[/url]
Similar topics
» Atom2Vec - Stanford AI recreates chemistry’s periodic table of elements
» Mathis' Chemistry Graphics
» The Gnome Chemistry Utils 0.14.0
» Hydrocarbon Formation and the Charge Field
» The NIST Computational Chemistry Comparison and Benchmark DataBase
» Mathis' Chemistry Graphics
» The Gnome Chemistry Utils 0.14.0
» Hydrocarbon Formation and the Charge Field
» The NIST Computational Chemistry Comparison and Benchmark DataBase
Miles Mathis' Charge Field :: Miles Mathis Charge Field :: The Charge Field Effects on Humans/Animals
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum